Cleared Traditional

K131193 - ACTITOUCH ACT-ADAPTIVE COMPRESSION THERAPY SYSTEM

K131193 is an FDA 510(k) clearance for ACTITOUCH ACT-ADAPTIVE COMPRESSION THER..., manufactured by Tactile Systems Technology, Inc.. The device is a Class 2 Cardiovascular device with product code JOW cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K131193 · Tactile Systems Technology, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
53d
Days
Class 2
Risk

K131193 is an FDA 510(k) clearance for the ACTITOUCH ACT-ADAPTIVE COMPRESSION THERAPY SYSTEM. Classified as Sleeve, Limb, Compressible (product code JOW), Class II - Special Controls.

Submitted by Tactile Systems Technology, Inc. (Minneapolis, US). The FDA issued a Cleared decision on June 18, 2013 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K131193

510(k) Number K131193 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2013
Decision Date June 18, 2013
Days to Decision 53 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 125d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JOW Device Classification - Class 2, Special Controls

Product Code JOW Sleeve, Limb, Compressible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - JOW Sleeve, Limb, Compressible

All 338
Devices cleared under the same product code (JOW) and FDA review panel - the closest regulatory comparables to K131193.
BIOARTERIAL PLUS ARTERIAL BLOOD FLOW ENHANCEMENT SYSTEM
K131327 · Bio Compression Systems, Inc. · Jul 2013
CIRONA DVT FOOT GARMENT
K131743 · Devon Medical, Inc. · Jul 2013
AIRCAST VENAFLOW ELITE SYSTEM
K130722 · Djo, LLC · Jun 2013
DVTCARE CA5
K130174 · Ossur Americas, Inc. · May 2013
DEVON CIRONA 6100 DVT
K130571 · Devon Medical, Inc. · Apr 2013
CIRCUFLOW 5150
K123959 · Devon Medical, Inc. · Feb 2013